NCT04839809View on ClinicalTrials.gov

A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

October 8, 2021

Study Completion Date

October 8, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

CC-92480

Oral

OTHER

Placebo

Oral

Trial Locations (1)

78744

PPD Phase 1 Clinic, Austin

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT04839809 - A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Participants | Biotech Hunter | Biotech Hunter